Evidence map›Paper›PMID 3893774›Full record

ReviewBulletin of the World Health Organization1985

Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis.

I de Zoysa, R G Feachem

Abstract readReview
In one paragraph

Review in Bulletin of the World Health Organization, 1985. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Erythromycin-resistant Campylobacter infections in Thailand.Antimicrobial agents and chemotherapy · 1987
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

I de Zoysa
R G Feachem

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of situations place young children at increased risk of diarrhoea. Among these, the best documented in developing countries is contact with a diarrhoea case in a family or household. The most common application of chemoprophylaxis in developing countries is to prevent cholera or shigellosis among household contacts of known cases. There is little evidence that chemoprophylaxis is effective in reducing diarrhoea morbidity and mortality, except perhaps in travellers. Theoretical calculations in this paper (based on optimistic assumptions) suggest that chemoprophylaxis of household contacts of known cholera cases in Bangladesh might reduce overall diarrhoea incidence rates in children under 5 years of age by 0.02-0.06% and diarrhoea mortality rates by 0.4-1.2%. Chemoprophylaxis of household contacts of known shigellosis cases might reduce overall diarrhoea incidence rates by 0.15-0.35% and diarrhoea mortality rates by 0.3-0.7% in the same age group. The correct identification of index cases of cholera and shigellosis, followed by the rapid distribution of drugs to their household contacts, requires skills and resources that are scarce in the developing countries. Chemoprophylaxis can contribute to the widespread emergence and dissemination of antimicrobial resistance. The available evidence suggests that chemoprophylaxis is not feasible in many settings and that, even if successfully implemented, it is not a cost-effective intervention for national diarrhoeal diseases control programmes.

Indexed as

Child, PreschoolCholeraDiarrheaDysentery, BacillaryHumansBiologyDelivery Of Health CareDemographic FactorsDiarrhea, Infantile--prevention and controlDiarrhea--prevention and controlDiseasesDrugs--administraction and dosageGastrointestinal EffectsHealthHealth ServicesMedicineMortalityPhysiologyPopulationPopulation DynamicsPreventive MedicineTreatment

Identifiers

PMID3893774
PMCPMC2536396
OpenAlexW147634428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.